Hamersma J, Cardon L R, Bradbury L, Brophy S, van der Horst-Bruinsma I, Calin A, Brown M A
University Hospital Vrije Universiteit, Armsterdam, The Netherlands.
Arthritis Rheum. 2001 Jun;44(6):1396-400. doi: 10.1002/1529-0131(200106)44:6<1396::AID-ART233>3.0.CO;2-A.
To assess the role of genes and the environment in determining the severity of ankylosing spondylitis.
One hundred seventy-three families with >1 case of ankylosing spondylitis were recruited (120 affected sibling pairs, 26 affected parent-child pairs, 20 families with both first- and second-degree relatives affected, and 7 families with only second-degree relatives affected), comprising a total of 384 affected individuals. Disease severity was assessed by the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and functional impairment was determined using the Bath Ankylosing Spondylitis Functional Index (BASFI). Disease duration and age at onset were also studied. Variance-components modeling was used to determine the genetic and environmental components contributing to familiality of the traits examined, and complex segregation analysis was performed to assess different disease models.
Both the disease activity and functional capacity as assessed by the BASDAI and the BASFI, respectively, were found to be highly familial (BASDAI familiality 0.51 [P = 10(-4)], BASFI familiality 0.68 [P = 3 x 10(-7)]). No significant shared environmental component was demonstrated to be associated with either the BASDAI or the BASFI. Including age at disease onset and duration of disease as covariates made no difference in the heritability assessments. A strong correlation was noted between the BASDAI and the BASFI (genetic correlation 0.9), suggesting the presence of shared determinants of these 2 measures. However, there was significant residual heritability for each measure independent of the other (BASFI residual heritability 0.48, BASDAI 0.36), perhaps indicating that not all genes influencing disease activity influence chronicity. No significant heritability of age at disease onset was found (heritability 0.18; P = 0.2). Segregation studies suggested the presence of a single major gene influencing the BASDAI and the BASFI.
This study demonstrates a major genetic contribution to disease severity in ankylosing spondylitis. As with susceptibility to ankylosing spondylitis, shared environmental factors play little role in determining the disease severity.
评估基因和环境在强直性脊柱炎严重程度决定中的作用。
招募了173个有1例以上强直性脊柱炎病例的家庭(120对受累同胞对、26对受累亲子对、20个有一级和二级亲属均受累的家庭以及7个只有二级亲属受累的家庭),共包括384名受累个体。通过巴斯强直性脊柱炎疾病活动指数(BASDAI)评估疾病严重程度,使用巴斯强直性脊柱炎功能指数(BASFI)确定功能损害情况。还研究了疾病持续时间和发病年龄。采用方差成分模型确定影响所检查性状家族聚集性的遗传和环境成分,并进行复杂分离分析以评估不同的疾病模型。
分别通过BASDAI和BASFI评估的疾病活动度和功能能力均显示出高度的家族聚集性(BASDAI家族聚集性0.51 [P = 10(-4)],BASFI家族聚集性0.68 [P = 3×10(-7)])。未发现有显著的共享环境成分与BASDAI或BASFI相关。将发病年龄和疾病持续时间作为协变量纳入,在遗传度评估中并无差异。BASDAI和BASFI之间存在强相关性(遗传相关性0.9),表明这两项指标存在共同的决定因素。然而,每项指标独立于另一项指标均存在显著的残余遗传度(BASFI残余遗传度0.48,BASDAI 0.36),这可能表明并非所有影响疾病活动度的基因都影响慢性病程。未发现发病年龄有显著的遗传度(遗传度0.18;P = 0.2)。分离分析提示存在一个影响BASDAI和BASFI的单一主基因。
本研究表明基因对强直性脊柱炎的疾病严重程度有主要贡献。与强直性脊柱炎易感性一样,共享环境因素在决定疾病严重程度方面作用很小。